Research Article
Diagnostic Power of Vascular Endothelial Growth Factor and Macrophage Colony-Stimulating Factor in Breast Cancer Patients Based on ROC Analysis
Table 2
Diagnostic criteria of tested parameters and in combined analysis with CA 15-3 in breast cancer patients.
| Tested parameters | Diagnostic criteria (%) | Breast cancer | Total group | Stage I | Stage II | Stage III | Stage IV |
| VEGF | SE | 76.25 | 75 | 75 | 85 | 70 | SP | 85 | 85 | 85 | 85 | 85 |
| M-CSF | SE | 60 | 25 | 35 | 85 | 95 | SP | 90 | 90 | 90 | 90 | 90 |
| CA 15-3 | SE | 83.75 | 65 | 75 | 95 | 100 | SP | 75 | 75 | 75 | 75 | 75 |
| VEGF + CA 15-3 | SE | 96.25 | 90 | 95 | 100 | 100 | SP | 65 | 65 | 65 | 65 | 65 |
| M-CSF + CA 15-3 | SE | 91.25 | 80 | 85 | 100 | 100 | SP | 67.5 | 67.5 | 67.5 | 67.5 | 67.5 |
| VEGF + M-CSF + CA 15-3 | SE | 96.25 | 90 | 95 | 100 | 100 | SP | 57.5 | 57.5 | 57.5 | 57.5 | 57.5 |
|
|